Health products• Updated Jan 3• APO-Amitriptyline
APO-AMITRIPTYLINE Tablets recall in Canada: Contamination risk
This recall involves APO-AMITRIPTYLINE Tablets sold in Canada. They are being recalled because they contain an impurity
All product recalls associated with APO-Amitriptyline in Canada, sourced from Health Canada, Transport Canada, and the CFIA.
This recall involves APO-AMITRIPTYLINE Tablets sold in Canada. They are being recalled because they contain an impurity
This recall involves APO-AMITRIPTYLINE 10mg tablets sold in Canada. It's being recalled because it contains an NDMA impu...
This recall involves APO-AMITRIPTYLINE 10mg tablets sold in Canada. It's being recalled because it contains higher than
This recall involves APO-AMITRIPTYLINE 10mg tablets sold in Canada. It's being recalled because it contains higher than